Clinical trialNCT06540963RecruitingPhase 2Interventional

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

SponsorGiselle ShollerEnrollment98Neuroblastoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Valerie Brown, MD, PhD
Beat Childhood Cancer
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Michael Bishop
Recruiting
Connecticut Children'S Hospital
Hartford, Connecticut, United States
Michael Isakoff
Recruiting
Nicklaus Children'S Hospital
Miami, Florida, United States
Guillermo De Angulo
Recruiting
Arnold Palmer Hospital for Children
Orlando, Florida, United States
Jamie Libes-Bander
Recruiting
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
Kelly Hutchins
Recruiting
Cardinal Glennon Children'S Medical Center
St Louis, Missouri, United States
William Ferguson
Recruiting
Duke University
Durham, North Carolina, United States
Jessica Sun
Recruiting
Randall Children'S Hospital
Portland, Oregon, United States
Jason Glover
Recruiting
Penn State Milton S. Hershey Medical Center and Children'S Hospital
Hershey, Pennsylvania, United States
Valerie Brown
Recruiting
Monroe Carrell Jr. Children'S Hospital at Vanderbilt
Nashville, Tennessee, United States
Daniel Benedetti
Recruiting
Dell Children'S Blood and Cancer Center
Austin, Texas, United States
Virginia Harrod
Recruiting
Children'S Medical Center
Dallas, Texas, United States
Tanya Watt
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Dec 2024
Primary completion: 1 Dec 2030
Completion: 1 Dec 2035
Last update posted: 28 Apr 2026
Registered enrollment: 98
Registry id: NCT06540963

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.